Startup profile for Nous Research: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Nous Research funding, valuation and investors

Open-source AI lab behind the Hermes agent and distributed model-training infrastructure.

Keep track of Nous Research

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$90M · October 7, 2026

Latest known valuation

$1.5B

Series B · October 7, 2026

Total disclosed equity funding

$140M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · Austin, Texas

Sources: latest funding Last verified: 2026-10-07

Overview

Nous Research develops open-source AI models, agents and distributed training systems. Its Hermes family targets developers and, after the 2026 Series B, enterprise users seeking more control over models and data. The company raised a $50 million Series A led by Paradigm in April 2025 and a $90 million Series B led by Robot Ventures in October 2026.

Why Nous Research is interesting

Nous combines open-source model development with an enterprise agent product. Its Series B tests whether popularity among developers can become durable corporate revenue without abandoning open distribution.

Product & use cases

Hermes is an open-source AI agent and model family. Nous also develops Psyche, a distributed training system intended to coordinate compute across multiple participants.

  • Deploying customizable AI agents inside enterprise environments
  • Running open models without dependence on one proprietary API vendor
  • Distributed training experiments through Psyche

Key facts

  • October 7, 2026: raised $90M Series B at a $1.5B valuation, taking total funding to about $158M.
  • The company said Hermes recorded more than 22 million downloads after its February 2026 launch; this is a company-reported adoption figure.
  • April 25, 2025: raised $50M Series A led by Paradigm.

Funding history (newest first)

Investors in our directory

Funds linked from Nous Research's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: A large developer audience around Hermes and open-source distribution can lower adoption friction, while Psyche provides a differentiated distributed-training narrative.

Nous must convert downloads into enterprise revenue while competing with better-capitalized model providers and other open-weight ecosystems. Control, deployment flexibility and community adoption are advantages; reliability, support and model economics will determine enterprise retention.

  • OpenClaw direct

    Open-source agent competitor with strong developer adoption.

  • OpenAI alternative

    Proprietary models and agent products with broader enterprise distribution.

  • Anthropic alternative

    Proprietary enterprise models and coding agents.

  • Mistral AI direct

    Open-weight model developer serving enterprise customers.

Industries

Market / IPO context

Editorial / static context — not a live quote.

Related funding articles

Venture Capital Tracker pieces that cover Nous Research's financing or category context.

FAQs about Nous Research

Practical answers founders, operators, and investors typically search for.

Nous Research raised $90 million in its October 2026 Series B, taking total funding to about $158 million.
The October 2026 Series B valued Nous Research at $1.5 billion.
Robot Ventures led the round.
Hermes is Nous Research's open-source family of AI models and agents.
Nous must convert developer downloads into reliable enterprise revenue while competing with both proprietary and open-model providers.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.